Announcement
21 Mar 2020
In March 2020, BARDA announced providing funding to support Cue Health Inc. in the development of a rapid, point-of-care SARS-CoV-2 Test.
Source
Number of interventions
1
1 certainly harmful
0 likely harmful
0 liberalising
Implementation date
21 Mar 2020
Revocation date:
No revocation date
On 21 March 2020, Biomedical Advanced Research and Development Authority (BARDA) announced providing USD 13.7 million to support Cue Health Inc. in the development of a molecular diagnostic test ca...
See all
This state act is not part of any Thread yet.